PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Animal Facility, Istituto Nazionale Tumori, Istituto Di Ricovero e Cura a Carattere Scientifico \'Fondazione G. Pascale\', Naples, Italy.\', \'Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.\', \'Division of Cardiology, Istituto Nazionale Tumori, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) \'Fondazione G. Pascale\', Naples, Italy.\', \'Section of Histology, Department of Experimental Medicine, University of Campania \'Luigi Vanvitelli\', Naples, Italy.\', \'Scientific Directorate, Istituto Nazionale Tumori, IRCCS \'Fondazione G. Pascale\', Naples, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2020.588724
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33117402
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33117402>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33117402>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all